Africa Contraceptive Drugs and Devices Market - Growth, Trends, and Forecast (2020 - 2025)

The market is segmented by Products (Drugs and Devices) and Gender.

Market Snapshot

Study Period:

2017-2025

Base Year:

2019

CAGR:

7.2 %

Major Players:

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Market Overview

An unintended pregnancy occurs from not using contraception or by an inconsistent and incorrect use of contraceptive methods. The growth of the contraceptives markets is the necessity to avoid unwanted pregnancies and their complications, especially in the teenagers. Teenage pregnancy is a big problem in Africa. The Limpopo Department of Health has estimated that around 182,000 South African teenagers are found becoming pregnant each year. Pregnant teenagers face serious health, socio-economic, and educational challenges. According to an article by Jyothi Laldas in 2018, girls between the ages of 15 and 19-years old account for 11% of births worldwide. Of this, almost 95% births are in low- to middle-income countries. An increase in the unplanned pregnancies has helped in the growth of the market. The other factors such as increasing incidence of the STDs and rise in government initiatives is also expected to propel the market growth over the forecast period.

Scope of the report

As per the scope of the report, contraceptive drugs and devices are used for birth control. Contraception is more commonly known as fertility and birth control, which is described as the method to avoid pregnancy.

By Products
By Drugs
Oral Contraceptives
Topical Contraceptives
Contraceptive Injectable
By Device
Condoms
Diaphragms
Cervical Caps
Sponges
Vaginal Rings
IUD
Other Devices
By Gender
Male
Female

Report scope can be customized per your requirements. Click here.

Key Market Trends

Oral Contraceptives Segment is Expected to Show Better Growth in the Forecast Years

Based on Drugs, the market is segmented into Oral Contraceptives, Topical Contraceptives and Contraceptive Injectable. Oral contraceptive pills are considered as the easiest method of contraception in the industry. They act by prohibiting implantation within the uterus if taken within 2-3 days of having unsafe sexual contact. These are easily marketed across large regions by several companies and thus easily consumed by a large section of the population. According to WHO, in 2018, around 214 million women of reproductive age in developing countries who want to avoid pregnancy are not using a modern contraceptive method. In Africa, 24.2% of women of reproductive age have an unmet need for modern contraception, as per the WHO estimates. Hence, the rising demand of contraceptives to avoid unintended pregnancies, along with rising government initiatives are expected to drive the market in the forecast period.

To understand key trends, Download Sample Report

Competitive Landscape

The market studied is moderately competitive and there are several local as well international companies in Africa who deal with the contraceptives. The major players in the Africa contraceptive drugs and devices market are Allergan PLC, Bayer AG, Johnson & Johnson, Lupin Limited, Merck & Co. Inc., Mylan N.V., Pfizer Inc. and Teva Pharmaceutical Industries Ltd.

Table Of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Increasing Incidence of the STDs

      2. 4.2.2 Increase in Unplanned Pregnancies

      3. 4.2.3 Rise in Government Initiatives

    3. 4.3 Market Restraints

      1. 4.3.1 Side Effects Associated with the Use of Contraceptive Drugs and Devices

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Products

      1. 5.1.1 By Drugs

        1. 5.1.1.1 Oral Contraceptives

        2. 5.1.1.2 Topical Contraceptives

        3. 5.1.1.3 Contraceptive Injectable

      2. 5.1.2 By Device

        1. 5.1.2.1 Condoms

        2. 5.1.2.2 Diaphragms

        3. 5.1.2.3 Cervical Caps

        4. 5.1.2.4 Sponges

        5. 5.1.2.5 Vaginal Rings

        6. 5.1.2.6 IUD

        7. 5.1.2.7 Other Devices

    2. 5.2 By Gender

      1. 5.2.1 Male

      2. 5.2.2 Female

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Allergan PLC

      2. 6.1.2 Bayer AG

      3. 6.1.3 Johnson & Johnson

      4. 6.1.4 Lupin Limited

      5. 6.1.5 Merck & Co. Inc.

      6. 6.1.6 Mylan N.V.

      7. 6.1.7 Pfizer Inc.

      8. 6.1.8 Teva Pharmaceutical Industries Ltd.

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments

Related Reports